Literature DB >> 1920091

Area under the curve, bioavailability, and clearance.

A Rescigno1, A Marzo.   

Abstract

Mesh：

Year:  1991        PMID： 1920091     DOI： 10.1007/bf01061668

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  1 in total

1.  The use and abuse of models.

Authors:  A Rescigno; J S Beck
Journal:  J Pharmacokinet Biopharm       Date:  1987-06
  1 in total
  3 in total

1.  When is a metric not a metric? Remarks on direct curve comparison in bioequivalence studies.

Authors:  Wojciech Jawień
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-06-21       Impact factor: 2.745

Review 2.  Some pharmacokinetic considerations about homeostatic equilibrium of endogenous substances.

Authors:  A Marzo; A Rescigno; E Arrigoni Martelli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Apr-Jun       Impact factor: 2.441

Review 3.  Pharmacokinetics of endogenous substances: some problems and some solutions.

Authors:  A Marzo; A Rescigno
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.